medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2021, Number 3

<< Back Next >>

Acta Med 2021; 19 (3)

Miller Fisher syndrome and polyneuritis cranialis as manifestation of COVID-19

Alcocer MJL, Domínguez CLG

Language: Spanish
References: 19
Page: 368-371
PDF size: 164.57 Kb.


ABSTRACT

Introduction: The SARS-CoV-2 pandemic has caused an avalanche of information about the affectation of different systems including the central and peripheral nervous systems. Objective: Report the first case in the locality with acute respiratory syndrome due to SARS-CoV-2 that acutely presented Miller Fisher syndrome and facial diplegia. Clinical case: 46-year-old female who initially presented anosmia, ageusia, right ophthalmoparesis, passing to bilateral ophthalmoplegia, mild ataxia, areflexia, facial diplegia, moderate dysphagia, albumine-cytological dissociation in CSF and positive test for GD1b-IgG antibodies. Five days earlier, she had developed a cough, malaise, headache, and fatigue. The oropharyngeal smear test for (COVID-19) by the qualitative real-time reverse transcriptase polymerase chain reaction assay was positive, being negative in CSF. Managed with intravenous immunoglobulin and acetaminophen. Two weeks after discharge, she was referred to rehabilitation for the physical management of facial diplegia. Conclusions: The first case of Miller Fisher syndrome and cranial polyneuritis during the COVID-19 pandemic is reported in Leon, Guanajuato, Mexico. Neurological manifestations can occur due to an aberrant immune response to COVID-19.


REFERENCES

  1. Dubé M, Le Coupanec A, Wong AHM, Rini JM, Desforges M, Talbot PJ. Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J Virol. 2018; 92 (17): e00404-18.

  2. Carod-Artal FJ. Complicaciones neurológicas por coronavirus y COVID-19. Rev Neurol. 2020; 70: 311-322.

  3. Chao CC, Tsai LK, Chiou YH, Tseng MT, Hsieh ST, Chang SC et al. Peripheral nerve disease in SARS: report of a case. Neurology. 2003; 61 (12): 1820-1821.

  4. Stainsby B, Howitt S, Porr J. Neuromusculoskeletal disorders following SARS: a case series. J Can Chiropr Assoc. 2011; 55 (1): 32-39.

  5. Rodríguez UJ, Delgado LF, Franco ME, Bernal SM, Martínez CQ, Palomino AG. Síndrome de Miller-Fisher: hallazgos clínicos, infecciones asociadas y evolución en 8 pacientes. Med Clin. 2004; 122 (6): 223-226.

  6. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med. 1956; 255 (2): 57-65.

  7. Dinkin M, Gao V, Kahan J, Bobker S, Simonetto M, Wechsler P et al. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. 2020; 95 (5): 221-223.

  8. Santos ME, Cabrera AE, Gudiño FE, Jiménez HM, Hernández BR, Hernández BR et al. Síndrome de Miller Fisher. Arch Neurocien (Mex). 2007; 12 (3): 180-182.

  9. Zaldívar RJM, Sosa HJ, García TD, Guillén CAM, Pérez AOL. Síndrome de Miller Fisher. A propósito de un caso. Rev Ciencias Médicas. 2011; 15 (2): 261-268.

  10. Wang Y, Lang W, Zhang Y, Ma X, Zhou C, Zhang HL. Long-term prognosis of Guillain-Barré syndrome not determined by treatment options? Oncotarget. 2017; 8 (45): 79991-80001. doi: 10.18632/oncotarget.20620.

  11. Mao L, Wang M, Chen S, He Q, Chang J, Hong C et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. MedRxiv. 2020. doi: 10.1101/2020.02.22.20026500.

  12. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020; 19 (5): 383-384.

  13. Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020; 382 (26): 2574-2576. doi: 10.1056/NEJMc2009191.

  14. Gutiérrez-Ortiz C, Méndez-Guerrero A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, Gordo-Mañas R et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020; 95 (5): e601-e605. doi: 10.1212/WNL.0000000000009619.

  15. Román GC, Spencer PS, Reis J, Buguet A, Faris MEA, Katrak SM et al. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. J Neurol Sci. 2020; 414: 116884.

  16. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020; 109: 102433.

  17. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020; 92 (6): 552-555. doi: 10.1002/jmv.25728.

  18. Orozco-Hernández JP, Marin-Medina DS, Sánchez-Duque JA. Neurological manifestations of SARS-CoV-2 infection. Semergen. 2020; 46 Suppl 1: 106-108. doi: 10.1016/j.semerg.2020.05.004.

  19. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020; 87: 18-22. doi: 10.1016/j.bbi.2020.03.031.




2020     |     www.medigraphic.com